Psilocybin vs Nicotine Patches: What a New Study Reveals About Quitting Smoking
Growing evidence supports the use of psychedelics in the treatment of substance use disorders (SUDs). These compounds may be uniquely positioned to intervene across multiple levels of addiction pathology, with emerging research suggesting that psychedelics may exert therapeutic effects by modulating maladaptive neural circuitry, increasing cognitive flexibility, and disrupting rigid patterns of self-related thought. (1) [β¦] The post Psilocybin vs Nicotine Patches: What a New Study Reveals About Quitting Smoking appeared first on OPEN Foundation.
External link. We are not responsible for the content.
Read more βMore From OPEN Foundation
The Therapeutic Potential of Psychedelics in the Treatment of Substance Use Disorders
Substance use disorders (SUDs) remain among the most persistent global public health challenges. Despite decades of p...
Ketamine-Assisted Psychotherapy for Mental Disorders: What Does the Evidence Actually Show?
A new systematic review in Clinical Psychology Review offers the most comprehensive overview to date of studies combi...
The Perils of Non-Hallucinogenic Claims: On the Limits of Translatability
This is Part II of a double feature discussing the current stage in research and development of the different classes...
Latest News
Senate Bill S.4031 Signals a Federal Turn Toward Psychedelic Medicine
Senate bill S.4031 would establish VA Centers of Excellence to study psychedelic therapies β including MDMA, psilocyb...
Psychedelic Culture 2026
Psychedelic Culture 2026 is Chacruna Instituteβs annual three-day conference bringing together researchers, Indigenou...
TRYP EXPO
TRYP Expo is Europeβs first major gathering at the intersection of psychedelic science, mental health, wellness, and ...
A Trip to Sobriety: Psychedelics and Addiction
Growing evidence suggests psychedelics could help treat addiction β particularly from tobacco, alcohol, and opioids β...
Federal Support for U.S. Psychedelic Research Accelerates 5-MeO-DMT Clinical Trials
The rescheduling of cannabis by executive order and the FDA's acceleration of research into potential 5-MeO-DMT thera...
Dolphins, LSD, and floating tanks : 5 Questions for filmmaker Courtney Stephens
Stephens discusses her documentary on the controversial scientist John C. Lilly.